Trial intelligence / Profile preview

Comparing efficacy of different doses of triamcinolone acetonide injection in De Quervain's tenosynovitis

TCTR20250412004Phase 4Completed

Sponsor
N/A
Start
Apr 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of triamcinolone acetonide in de Quervain's tenosynovitis, sponsored by N/A. Started Apr 2024; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

de Quervain's tenosynovitis

Beyond the preview

Go deeper on TCTR20250412004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250412004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call